J. Blazquez et al., A237T AS A MODULATING MUTATION IN NATURALLY-OCCURRING EXTENDED-SPECTRUM TEM-TYPE BETA-LACTAMASES, Antimicrobial agents and chemotherapy, 42(5), 1998, pp. 1042-1044
A TEM-1 beta-lactamase derivative containing the single amino acid sub
stitution A237T slightly increased (from 24 to 32 mu g/ml) the cephalo
thin MIC for Escherichia coli RYC1000 but did not influence the activi
ties of cefotaxime, ceftazidime, and aztreonam (MICs of 0.03, 0.12, an
d 0.06 mu g/ml, respectively), Despite its apparent neutrality, additi
on of the A237T mutation to the pair of mutations characterizing TEM-I
O (R164S and E240K) had a strong effect on substrate preference. Cefta
zidime and aztreonam MICs decreased from 128 and 16 mu g/ml to 16 and
2 mu g/ml, respectively. In contrast, the cefotaxime MIC increased fro
m 0.5 to 4 mu g/ml. The acquisition of apparently neutral or even dele
terious mutations results in a very effective mechanism of resistance
to different beta-lactams that may be simultaneously or subsequently p
resent in the environment. We propose here that the mutation in positi
on 237 is an example of a modulating mutation and that consideration o
f this type of mutation may be important for understanding the evoluti
on of beta-lactamases.